|
| 35995710 | Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer. | Eur Urol Oncol | 2023 |
| 36002248 | Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment. | Gut | 2023 |
| 35995710 | Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer. | Eur Urol Oncol | 2023 |
| 37738407 | Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases. | Cancer Res | 2023 |
| 38002248 | Tumor-Associated and Systemic Autoimmunity in Pre-Clinical Breast Cancer among Post-Menopausal Women. | Biomolecules | 2023 |
| 37729870 | A blood-based metabolomic signature predictive of risk for pancreatic cancer. | Cell Rep Med | 2023 |
| 37581614 | SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression. | Clin Cancer Res | 2023 |
| 37724990 | Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome. | Clin Cancer Res | 2023 |
| 37645752 | Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alteration. | bioRxiv | 2023 |
| 37289498 | A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept. | Immunohorizons | 2023 |
| 36824840 | Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. | Res Sq | 2023 |
| 36765792 | Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis. | Cancers (Basel) | 2023 |
| 36765581 | c-MYC-Driven Polyamine Metabolism in Ovarian Cancer: From Pathogenesis to Early Detection and Therapy. | Cancers (Basel) | 2023 |
| 37379494 | Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort. | J Clin Oncol | 2023 |
| 37307230 | Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression. | J Clin Endocrinol Metab | 2023 |
| 37419119 | Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression. | Cancer Cell | 2023 |
| 38002248 | Tumor-Associated and Systemic Autoimmunity in Pre-Clinical Breast Cancer among Post-Menopausal Women. | Biomolecules | 2023 |
| 37581614 | SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression. | Clin Cancer Res | 2023 |
| 37738407 | Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases. | Cancer Res | 2023 |
| 37645752 | Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alteration. | bioRxiv | 2023 |
| 37729870 | A blood-based metabolomic signature predictive of risk for pancreatic cancer. | Cell Rep Med | 2023 |
| 37724990 | Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome. | Clin Cancer Res | 2023 |
| 37289498 | A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept. | Immunohorizons | 2023 |
| 37419119 | Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression. | Cancer Cell | 2023 |
| 37379494 | Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort. | J Clin Oncol | 2023 |
| 37307230 | Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression. | J Clin Endocrinol Metab | 2023 |
| 36765792 | Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis. | Cancers (Basel) | 2023 |
| 36765581 | c-MYC-Driven Polyamine Metabolism in Ovarian Cancer: From Pathogenesis to Early Detection and Therapy. | Cancers (Basel) | 2023 |
| 36824840 | Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. | Res Sq | 2023 |
| 36002248 | Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment. | Gut | 2023 |
| 34524427 | SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. | J Natl Cancer Inst | 2022 |
| 35767954 | Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids. | Cell Rep | 2022 |
| 36037307 | A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses. | Clin Cancer Res | 2022 |
| 36291787 | Deep Learning Models for Automated Assessment of Breast Density Using Multiple Mammographic Image Types. | Cancers (Basel) | 2022 |
| 36291752 | Mining the Immunopeptidome for Antigenic Peptides in Cancer. | Cancers (Basel) | 2022 |
| 35958329 | Lung cancer susceptibility beyond smoking history: opportunities and challenges. | Transl Lung Cancer Res | 2022 |
| 35759080 | Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting. | Cancer Causes Control | 2022 |
| 36012199 | A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response. | Int J Mol Sci | 2022 |
| 36077796 | Novel UHRF1-MYC Axis in Acute Lymphoblastic Leukemia. | Cancers (Basel) | 2022 |
| 36077759 | Contributions of Circulating microRNAs for Early Detection of Lung Cancer. | Cancers (Basel) | 2022 |
| 35626147 | Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma. | Cancers (Basel) | 2022 |
| 36384092 | A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma. | Cell Rep Med | 2022 |
| 34524427 | SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. | J Natl Cancer Inst | 2022 |
| 34971802 | CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop. | Mol Metab | 2022 |
| 34995129 | Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. | J Clin Oncol | 2022 |
| 35767954 | Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids. | Cell Rep | 2022 |
| 35759080 | Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting. | Cancer Causes Control | 2022 |
| 35626147 | Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma. | Cancers (Basel) | 2022 |
| 36037307 | A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses. | Clin Cancer Res | 2022 |
| 36384092 | A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma. | Cell Rep Med | 2022 |